Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 118698
Published online Aug 15, 2026. doi: 10.4251/wjgo.118698
Published online Aug 15, 2026. doi: 10.4251/wjgo.118698
Table 2 Comparison of blood pressure control before and after treatment, mean ± SD
| Group | Systolic blood pressure (mmHg) | Diastolic blood pressure (mmHg) | ||
| Before treatment | After treatment | Before treatment | After treatment | |
| Control group (n = 60) | 153.63 ± 5.19 | 126.42 ± 9.43 | 96.44 ± 3.72 | 82.69 ± 2.97 |
| Experimental group (n = 60) | 153.60 ± 5.29 | 119.04 ± 10.44 | 95.83 ± 3.92 | 78.90 ± 4.23 |
| t value | 0.025 | 4.064 | 0.877 | 5.685 |
| P value | 0.980 | < 0.001 | 0.382 | < 0.001 |
- Citation: Lou HC, Liu XH, Jin P, Wang JM, Liu B. Interaction between calcium channel blockers and capecitabine in colorectal cancer patients with hypertension. World J Gastrointest Oncol 2026; 18(8): 118698
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/118698.htm
- DOI: https://dx.doi.org/10.4251/wjgo.118698